Access cutting-edge angina patients with non-obstructive coronary artery disease treatment through this phase 1 clinical trial at a research site in Charlottesville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charlottesville location
Preparing your pre-screening questions…
Access angina patients with non-obstructive coronary artery disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related angina patients with non-obstructive coronary artery disease treatment provided free
Check if you qualify for this angina patients with non-obstructive coronary artery disease clinical trial in Charlottesville, VA
No-Cost Study Care
Local to Charlottesville
Convenient for VA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to that Sodium-glucose cotransporter 2 inhibitors treatment will improve Coronary Microvascular Disease with anginal symptoms associated with non-obstructive coronary disease in women. The main questions it aims to answer are: Aim 1: Test the hypothesis that Sodium-glucose cotransporter 2 inhibitors treatment improves coronary microvascular disease in women with no evidence of epicardial obstructive coronary artery disease. Aim 2: Test the hypothesis that Sodium-glucose cotransporter 2 inhibitors treatment improves angina symptoms and other quality of life measurements associated with the improvement of CFR. AIM 3: Identify the effect of Sodium-glucose cotransporter 2 inhibition on inflammation pathways and markers of systemic Research will compare Brezavvy to placebo Participants will: * Take study drug or placebo for 12 weeks * Stress Cardiac magnetic resonance imaging * 12 lead electrocardiograms * Complete questionnaires
Sponsor: University of Virginia
Yes, this clinical trial (NCT06600178) has an active research site in Charlottesville, VA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for angina patients with non-obstructive coronary artery disease treatment options in Charlottesville, VA, this clinical trial (NCT06600178) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charlottesville research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced angina patients with non-obstructive coronary artery disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all angina patients with non-obstructive coronary artery disease clinical trials near you to find additional studies recruiting in your area.
See all heart disease clinical trials recruiting in Charlottesville — not just this study.
Browse Heart Disease Trials in Charlottesville →